PREVENTION AND TREATMENT OF INFLAMMATORY CONDITIONS
申请人:GRI Bio, Inc.
公开号:EP3229811B1
公开(公告)日:2021-02-24
[EN] PREVENTION AND TREATMENT OF INFLAMMATORY CONDITIONS<br/>[FR] PRÉVENTION ET TRAITEMENT DE PATHOLOGIES INFLAMMATOIRES
申请人:GLYCOREGIMMUNE INC
公开号:WO2016094226A1
公开(公告)日:2016-06-16
In accordance with some embodiments herein, methods and compositions for prevention and treatment of inflammatory conditions are provided. In some embodiments, compositions comprising NKT-2 activators, for example miltefosine are provided. In some embodiments, the compositions further comprise sulfatide and/or a RAR agonist. In some embodiments, the compositions comprise activators of Type II NKT cells, and/or inhibitors of Type I NKT cells.
Diels; Alder, Justus Liebigs Annalen der Chemie, 1932, vol. 498, p. 16,26, 46
作者:Diels、Alder
DOI:——
日期:——
890. Addition reactions of heterocyclic compounds. Part VI. The hydrolysis of tetramethyl 4H-quinolizine-1,2,3,4-tetracarboxylate to indolizines